Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Treatment Response to Incretin Mimetics in Non-diabetic Obese Patients With and Without Insulin Resistance (TRIM-IR)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06856291
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:42.088148+00:00
Published At
2025-03-25T00:00:00+00:00
Record Updated At
2025-03-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Obesity and Obesity-related Medical Conditions", "Obesity and Overweight", "Insulin Sensitivity/Resistance", "Semaglutide"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-25"
protocolSection.identificationModule.nctId
"NCT06856291"
protocolSection.identificationModule.officialTitle
"Treatment Response to Incretin Mimetics in Non-diabetic Obese Patients With and Without Insulin Resistance (TRIM-IR)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Obesity and Obesity-related Medical Conditions (protocolSection.conditionsModule.conditions)
  • Obesity and Overweight (protocolSection.conditionsModule.conditions)
  • Insulin Sensitivity/Resistance (protocolSection.conditionsModule.conditions)
  • Semaglutide (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.